AkesoGenX's Unattributed Round

AkesoGenX raised a round of funding on June 12, 2013.

AkesoGenX bring to market significant new nano-diagnostic and nano-therapeutic medical products. The primary goal is to move the Kanzius RF field treatment forward to treat patients with highly lethal…

Articles about AkesoGenX's Unattributed Round: